Replies to post #6539 on Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[EM]

I could give you several examples about stock going flat after approval lol .... in any case question is: how could you hold a stock you are not comfortable to hold? That’s sounds crazy to me.

It went at 3,81 the day of approval from your 2,7 entry point and it was a good gain.

In any case, the only reason this is down is IMO that they still haven’t signed a licensing deal in US. You have an approved drug but no revenues.

[Amatuer17]

You are right - getting any drug approved th’ multiple phases - efforts - paperwork is very difficult.

After all that efforts, if there is no demand for that product and no one wants to buy it - means all efforts are wasted.

The high blood pressure medicine is a burden - no MID Cap or BP wants to waste efforts to market another generic product while original generic is available